- Shopping Bag ( 0 items )
From The CriticsReviewer: Michael Joel Schrift, D.O., M.A.(University of Illinois at Chicago College of Medicine)
Description: This monograph is a review of the available scales that assess outcomes in Alzheimer's disease. Edited and authored by internationally recognized dementia researchers, this is a valuable contribution to the field.
Purpose: The purpose, according to the editor, is to provide a critical review of outcome measures in Alzheimer's disease, especially with the availability of new drugs such as cholinesterase inhibitors.
Audience: The intended audience is clinicians, including psychiatrists, neurologists, geriatricians, and anyone involved with the care or treatment of people who are affected by dementia.
Features: The monograph features 76 pages divided into six chapters, including an up-to-date reference section. The chapters include topics such as cognitive function, global function, activities of daily living, neuropsychiatric symptoms, quality of life, and caregiver burden. There is a useful index at the end of the book.
Assessment: This is a unique and useful review of the current measures of outcome in Alzheimer's disease. Anyone who treats dementia should read this book.